MIMT1 and nonpapillary renal cell carcinoma: The high expression of STAR promoted the drug resistance of ccRCC cell lines to AZD1480 but enhanced the drug sensitivity of ccRCC cell lines to CAY10603, navitoclax, MIM1, and other drugs (Figure 11(d)).